Clinical and laboratory characteristics of children with Kawasaki disease

Abstract

Objective: In this study, we aimed to evaluate clinical and laboratory characteristics of patients with Kawasaki disease (KD) in Konya region of Turkey. Methods: The hospital records of patients who were hospitalized with the diagnosis of KD in the Pediatrics Clinics of Konya Training and Research Hospital between May 2010 and June 2012 were reviewed retrospectively. Results: Seven cases were found to have the diagnosis of KD, two of whom were incomplete KD. Oropharynx changes were the most common (100%) feature in our patients. Five (71%) patients had bulbar conjunctivitis. Three (43%) patients had erythema at the site of BCG inoculation. Adenopathy was present in all of our patients with the classical form. A desquamation was observed in one case at the seventh day of fever. No cardiac manifestation was seen. Elevated erythrocyte sedimentation rate and thrombocytosis were present in all patients. All of the patients were received intravenous immunoglobulin in the first ten days of the fever. Conclusion: KD should be considered as a possible diagnosis in any child presenting with prolonged fever. BCG reaction can be attributed as a diagnostic criterion for incomplete form of the disease especially in countries where BCG vaccination is routinely performed. Early treatment is essential to prevent cardiovascular complications. Key words: Kawasaki disease, vasculitis, BCG reaction, children

Keywords

• Kawasaki disease, vasculitis, BCG reaction, children

Kawasaki hastalığı bulunan çocukların klinik ve laboratuvar özellikleri

Abstract

Amaç: Bu çalışmada, kliniğimizde Kawasaki hastalığı (KH) tanısıyla takip ettiğimiz vakalarımızın klinik ve laboratuvar özelliklerini sunmayı amaçladık. Yöntemler: Konya Eğitim ve Araştırma Hastanesi Çocuk Sağlığı ve Hastalıkları Kliniği’ne Mayıs 2010 ve Haziran 2012 tarihleri arasında KH tanısıyla yatırılarak takip edilen hastaların kayıtları retrospektif olarak incelendi.Bulgular: Yedi vakanın Kawasaki hastalığı tanısıyla izlendiği tespit edildi. Bu vakaların ikisi inkomplet Kawasaki hastalığı tanısı almıştı. Hastalarımızın tümünde (%100) orafarenks bulguları mevcuttu. Beş hastada (%71) bulbar konjonktivit vardı. Üç hastada (%43) BCG aşı yerinde eritem gözlendi. Klasik Kawasaki hastalığı tanısı alanların tümünde servikal adenopati mevcuttu. Bir hastada ateşin yedinci gününde ortaya çıkan ve bir hafta içinde düzelen periungual deskuamasyon gözlendi. Tüm hastalarımızda yüksek eritrosit sedimentasyon hızı ve trombositoz mevcuttu. Takipleri süresince hastaların hiçbirinde kardiak komplikasyon gözlenmedi. Hastalarımızın tümü ateşin ilk 10 günü içinde IVIG tedavisi almıştı.Sonuç: Uzamış ateş şikayetiyle gelen her hastada ayırıcı tanıda KH düşünülmelidir. BCG aşısının rutin olarak uygulandığı ülkelerde BCG aşı yerinde gelişen eritem özellikle inkomplet KH’nda tanı kriteri olarak kullanılabilir. Kardiyovaskuler komplikasyonların gelişmesini önlemek açısından hastalığın erken tanısı tedavisinin başlanması çok önemlidir

Keywords

• Kawasaki hastalığı, vaskülit, BCG reaksiyonu, çocuk

References

1. Sundel RP, Petty RE. Kawasaki Disease. In: Cassidy JT, Petty
2. RE, eds. Textbook of Pediatric Rheumatology, 6th edn.
3. Philadelphia: Elsevier Saunders, 2011:505-520.
4. Kawasaki T. Acute febrile mucocutaneous syndrome with
5. lymphoid involvement with specific desquamation of the
6. fingers and toes in children. Arerugi 1967;16:178-222.
7. Ozen S, Bakkaloglu A, Dusunsel R, et al. Turkish Pediatric
8. Vasculitis Study Group. Childhood vasculitides in Turkey:

9. a nationwide survey. Clin Rheumatol 2007;26:196-200.
10. Burns JC. Kawasaki disease. Adv Pediatr 2001; 48:157-177.
11. Burgner D, Harnden A. Kawasaki disease: what is the epidemiology
12. telling us about the etiology? Int J Infect Dis 2005;
13. :185-194.
14. Plantin P, Blayo M, Dupré D, Schoenlaub P. BCG reactivation:
15. a rare but specific sign of Kawasaki disease. Presse
16. Med 1998; 27:716.
17. Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and
18. clinical features of incomplete Kawasaki disease. Acta Paediatr
19. ;83:1057-1060.
20. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki
21. disease in infants. Do we need criteria? West J Med
22. ;162:322-327.
23. Kayiran SM, Dindar A, Gurakan B. An evaluation of children
24. with Kawasaki disease in Istanbul: a retrospective followup
25. study. Clinics 2010;65:1261-1265.
26. Başara BB, Güler C, Eryılmaz Z, ve ark. T.C. Sağlık Bakanlığı
27. Sağlık İstatistikleri Yıllığı 2011, Bölüm:5 Sayfa:49,
28. Ankara, Türkiye, 2012.
29. Sireci G, Dieli F, Salerno A. T cells recognize an immunodominant
30. epitope of heat shock protein 65 in Kawasaki disease.
31. Mol Med 2000;6:581-590.
32. Kakisaka Y, Ohara T, Katayama S, et al. Human herpes
33. virus type 6 can cause skin lesions at the BCG inoculation
34. site similar to Kawasaki Disease. Tohoku J Exp Med
35. ;228:351-353.
36. Hsu YH, Wang YH, Hsu WY, Lee YP. Kawasaki disease
37. characterized by erythema and induration at the Bacillus
38. Calmette-Guérin and purified protein derivative inoculation
39. sites. Pediatr Infect Dis J 1987;6:576-578.
40. Uehara R, Igarashi H, Yashiro M, et al. Kawasaki disease
41. patients with redness or crust formation at the Bacille
42. Calmette-Guérin inoculation site. Pediatr Infect Dis J
43. ;29:430-433.
44. Binnetoğlu K, Kuşdal Y, Altun G, Babaoğlu K. Kocaeli
45. Bölgesinde Kawasaki Hastalığı Tanısı Alan 24 Hastanın
46. Klinik ve Epidemiyolojik Özellikleri. Çocuk Enf Derg
47. ; 4:71-75.
48. Lai CC, Lee PC, Wang CC, et al. Reaction at the bacillus
49. Calmette-Guérin inoculation site in patients with Kawasaki
50. disease. Pediatr Neonatol 2013;54:43-48.
51. Takayama J, Yanase Y, Kawasaki T. A study on erythematous
52. change at the site of the BCG inoculation. Acta Pediatr
53. Jpn 1982;86:567-572.
54. Seo JH, Yu JJ, Ko HK, et al. Diagnosis of incomplete Kawasaki
55. disease in infants based on an inflammation at the
56. Bacille Calmette-Guérin inoculation site. Korean Circ J
57. ;42:823-829.
58. Wang S, Best BM, Burns JC. Periungual desquamation
59. in patients with Kawasaki disease. Pediatr Infect Dis J
60. ;28:538-539.
61. Gülhan B, Kesici S, Beken S, et al. Varying clinical features
62. of Turkish Kawasaki disease patients. Turk J Pediatr
63. ;54:1-6.
64. Ozdemir H, Ciftçi A, Karbuz A, et al. Incomplete Kawasaki
65. disease in an infant presenting with only prolonged fever.
66. Turk J Pediatr 2013; 55:529-532.
67. Ozdemir H, Ciftçi E, Tapisiz A, et al. Clinical and epidemiological
68. characteristics of children with Kawasaki disease
69. in Turkey. J Trop Pediatr 2010;56:260-262.
70. Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic
71. characteristics of patients referred for evaluation
72. of possible Kawasaki disease. United States Multicenter
73. Kawasaki Disease Study Group. J Pediatr 1991;118:680-
74. -
75. Ting EC, Capparelli EV, Billman GF, et al. Elevated gamma-glutamy
76. l transferase concentrations in patients with
77. acute Kawasaki disease. Pediatr Infect Dis J 1998;17:431-
78. -
79. Newburger JW, Takahashi M, Gerber MA, et al; Committee
80. on Rheumatic Fever, Endocarditis, and Kawasaki Disease,
81. Council on Cardiovascular Disease in the Young, American
82. Heart Association. Diagnosis, treatment, and long-term
83. management of Kawasaki disease: a statement for health
84. professionals from the Committee on Rheumatic Fever, Endocarditis,
85. and Kawasaki Disease, Council on Cardiovascular
86. Disease in the Young, American Heart Association.
87. Pediatrics 2004;114:1708-1733.
88. American Academy of Pediatrics. Kawasaki disease. In:
89. Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red
90. Book: 2006 Report of the Committee on Infectious Diseases,
91. th edn. Elk Grove, Village, IL: American Academy of
92. Pediatrics; 2006: 414.
93. Newburger JW, Takahashi M, Burns JC, et al. The treatment
94. of Kawasaki syndrome with intravenous gamma globulin.
95. N Engl J Med 1986;315:341-347.